<DOC>
	<DOCNO>NCT01028781</DOCNO>
	<brief_summary>Patients undergo standard history physical examination detail objective clinical exam finding perform one co-investigators . The research coordinator obtain baseline value intensity pain , quality life , cop strategy . Baseline serum level inflammatory marker measure . Over course 12 week Thalidomide titrate tolerated achieve minimum 30 % reduction pain VAS week 2 .</brief_summary>
	<brief_title>Open Label Thalidomide Treatment Women With Chronic Pelvic Pain Associated With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>1 . Age &gt; 18 year 2 . Histologically/laparoscopically confirm endometriosis 3 . Chronic pelvic pain define nonmenstrual pain least two week previous month least 6 month 4 . VAS 6 baseline 5 . Failure , completion intolerance standard treatment modality ( oral contraceptive therapy , danazol , DepoProvera , DepoLupron ) 6 . Patients must give write informed consent . 7 . Patients must willing able comply FDAmandated S.T.E.P.S.Â® program . 1 . Pregnant and/or lactate female 2 . Users angiogenesis inhibitor 3 . Current use Rifampin , rifabutin , barbiturate , glucocorticoid , phenytoin , carbamazepine , chlorpromazine , reserpine , penicillin derivative , St. Johns Wart user oral contraceptive therapy 4 . Use aromatase inhibitor , Etanercept ( Enbrel ) , GnRH agonists ( DepoLupron ) , Danazol within past 3 month 5 . Use norethindrone acetate ( Aygestin ) prior month 6 . Seizure disorder 7 . Hepatitis , active infection ( upper respiratory infection , PID , etc ) 8 . History thromboembolic disease . 9 . Baseline neutropenia ( ANC &lt; 1000/mm^3 ) 10 . Any severe physical metal illness would interfere completion protocol 11 . Illicit drug alcohol abuse</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>